Physician profile
Autum Shaw
NPI 1144639170
$830.16
in general payments reported to CMS, 2019-2025
13 companies · $73.79 in 2025
The $73.79 reported for 2025 was less than what a typical Nurse Practitioner provider received nationally (typical 2025 total: $174).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $261 · 2022: $156 · 2023: $176 · 2024: $163 · 2025: $73.79.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $413.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $413.31 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Radius Health, INC. | $301.69 | 2021-2024 | Tymlos |
| Amgen INC. | $209.81 | 2021-2024 | Evenity, Prolia |
| Convatec INC. | $78.21 | 2021-2023 | |
| Abbott Laboratories | $41.98 | 2025 | Eterna |
| Kowa Pharmaceuticals America, INC. | $39.27 | 2023 | Seglentis |
| Alexion Pharmaceuticals, INC. | $32.61 | 2023-2024 | Strensiq |
| Fidia Pharma USA INC. | $29.13 | 2022 | |
| Boston Scientific Corporation | $21.13 | 2021 | |
| Ucb, INC. | $18.22 | 2022 | |
| Vertex Pharmaceuticals Incorporated | $17.43 | 2025 | |
| Integra Lifesciences Corporation | $14.66 | 2024 | Integra, Primatrix, Integra Dermal Regeneration Template |
| Si-Bone, INC. | $14.38 | 2025 | |
| Heron Therapeutics, INC. | $11.64 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Autum Shaw listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.